Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.84 CAD | -3.73% | +5.76% | -2.34% |
Sales 2024 * | 15.95M 11.66M | Sales 2025 * | 43.69M 31.94M | Capitalization | 265M 194M |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.78M | Net income 2025 * | -30M -21.93M | EV / Sales 2024 * | 15.7 x |
Net cash position 2024 * | 13.74M 10.04M | Net Debt 2025 * | 41.34M 30.22M | EV / Sales 2025 * | 7.01 x |
P/E ratio 2024 * |
-6.95
x | P/E ratio 2025 * |
-7.72
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.29% |
Latest transcript on Profound Medical Corp.
1 day | -3.73% | ||
1 week | +5.76% | ||
Current month | -5.08% | ||
1 month | -2.43% | ||
3 months | -10.41% | ||
6 months | -8.45% | ||
Current year | -2.34% |
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 10.84 | -3.73% | 3,688 |
24-04-25 | 11.26 | +4.26% | 5,850 |
24-04-24 | 10.8 | +2.08% | 2,915 |
24-04-23 | 10.58 | +0.09% | 1,100 |
24-04-22 | 10.57 | +3.12% | 4,389 |
Delayed Quote Toronto S.E., April 26, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 201M | |
+8.07% | 218B | |
+6.59% | 182B | |
+11.26% | 132B | |
+26.57% | 108B | |
+13.35% | 52.98B | |
-0.62% | 47.59B | |
-0.93% | 39.96B | |
+11.54% | 39.22B | |
+26.76% | 26.94B |
- Stock Market
- Equities
- PRN Stock